v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (12,281) $ (36,594)
Adjustments to reconcile net loss to cash and cash equivalents used in operating activities:    
Depreciation and amortization 3,454 3,589
Amortization of debt issuance costs and debt discount 2,467 6,003
Write-off of assets from clinical trials segment 0 2,398
Share-based compensation 2,756 2,210
Change in fair value of liability classified warrants (174) 96
Change in fair value of liability classified conversion option derivatives (1,753) 7,296
Deferred taxes 0 (32)
Loss on disposal of property and equipment 28 0
Changes in operating assets and liabilities:    
Accounts receivable (7,351) (8,969)
Other receivables (38) (228)
Inventories (3,136) (5,747)
Prepaid expenses and other current assets 1,811 1,250
Other assets (51) 3
Accounts payable 17,112 11,490
Change in operating leases (492) (120)
Accrued expenses and other current liabilities 7,353 2,262
Other non-current liabilities 20 (97)
Net cash and cash equivalents provided by (used in) operating activities 9,725 (15,190)
Cash flows from investing activities:    
Purchases of property and equipment (1,950) (1,536)
Proceeds from asset disposition 0 126
Net cash and cash equivalents used in investing activities (1,950) (1,410)
Cash flows from financing activities:    
Proceeds from private placement, net of offering costs 0 15,359
Proceeds from employee stock purchase plan 220 0
Payments made for financing of insurance payments (560) (456)
Principal payments on long-term debt 0 (20,000)
Principal payments on financing leases (17) (20)
Common stock issued for options exercised 111 2,340
Net cash and cash equivalents used in financing activities (246) (2,777)
Net increase (decrease) in cash and cash equivalents 7,529 (19,377)
Cash and cash equivalents at beginning of period 33,565 49,669
Cash and cash equivalents at end of period 41,094 30,292
Supplemental disclosure of noncash investing and financing activities:    
Right-of-use assets in connection with operating lease modifications 0 1,253
Principal exchange of convertible note for preferred stock 0 4,111
Purchases of property and equipment included in accounts payable 0 528
Financed insurance premiums 530 540
Cash paid for:    
Income taxes 0 0
Interest $ 1,756 $ 2,158